Same Drug Class

Imatinib vs Osimertinib

Imatinib vs Osimertinib: Overview

This comparison examines the pharmacological differences between Imatinib and Osimertinib.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Osimertinib — C28H33N7O2.

Molecular Weight: Imatinib — 493.6030 g/mol; Osimertinib — 499.6050 g/mol.

Type: Imatinib — Small molecule; Osimertinib — Small molecule.